Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma

Clinical Cancer Research

Volumn 19, Issue 21, 2013, Pages 5879-5889

  Lee, Hye Won ^a,b,c   Park, Young Mi ^b,c   Lee, Se Jeong ^a,b,d   Cho, Hyun Jung ^a,b   Kim, Duk Hwan ^d,e   Lee, Jung Il ^b   Kang, Myung Soo ^c   Seol, Ho Jun ^b   Shim, Young Mog ^f   Nam, Do Hyun ^a,b,c   Kim, Hyeon Ho ^b,c   Joo, Kyeung Min ^a,b,c,d  

^a Cancer Stem Cell Research Center   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Graduate School for Heath Sciences and Technology ^*  (South Korea)

^f Center for Genome Research   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FOCAL ADHESION KINASE; SCATTER FACTOR RECEPTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SURGERY; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION;

ACTINS; ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-MET; RNA INTERFERENCE;

EID: 84887060169     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-1181     Document Type: Article

References (30)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46: 765-81.
2. Cufer T, Ovcaricek T, O'Brien ME. Systemic therapy of advanced nonsmall cell lung cancer: major-developments of the last 5-years. Eur J Cancer 2013;49: 1216-25.
3. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350: 379-92.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59: 225-49.
5. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer 2006;106: 1624-33.
6. Bernards R, Weinberg RA. A progression puzzle. Nature 2002; 418: 823.
7. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9: 274-84.
8. Lee HW, Seol HJ, Choi YL, Ju HJ, Joo KM, Ko YH, et al. Genomic copy number alterations associated with the early brain metastasis of nonsmall cell lung cancer. Int J Oncol 2012;41: 2013-20.
9. Fritz G, Kaina B. Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 2006;6: 1-14.
10. Lambrechts A, Van Troys M, Ampe C. The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol 2004;36: 1890-909.
11. Kim JS, Kim JW, Han J, Shim YM, Park J, Kim DH. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Cancer Res 2006;66: 4049-54.
12. Kim JS, Han J, Shim YM, Park J, Kim DH. Aberrant methylation of Hcadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma. Cancer 2005;104: 1825-33.
13. Kim MJ, Shin HC, Shin KC, Ro JY. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens. Ann Diagn Pathol 2013;17: 85-90.
14. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007;101: 805-15.
15. Valcz G, Sipos F, Krenacs T, Molnar J, Patai AV, Leiszter K, et al. Increase of alpha-SMA(+) andCK(+) cells as an early sign of epithelialmesenchymal transition during colorectal carcinogenesis. Pathol Oncol Res 2012;18: 371-6.
16. Masszi A, Di Ciano C, Sirokmany G, Arthur WT, Rotstein OD, Wang J, et al. Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiolo Renal Physiol 2003;284:F911-24.
17. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003;4: 915-25.
18. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010;29: 4741-51.
19. Thomas CH, Collier JH, Sfeir CS, Healy KE. Engineering gene expression and protein synthesis by modulation of nuclear shape. Proc Natl Acad Sci U S A 2002;99: 1972-7.
20. Kim SH, Choe C, Shin YS, Jeon MJ, Choi SJ, Lee J, et al. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture. Anticancer Res 2013;33: 2001-9.
21. An J, Enomoto A, Weng L, Kato T, Iwakoshi A, Ushida K, et al. Significance of cancer-associated fibroblasts in the regulation of gene expression in the leading cells of invasive lung cancer. J Cancer Res Clin Oncol 2013;139: 379-88.
22. Siegfried JM, Weissfeld LA, Luketich JD, Weyant RJ, Gubish CT, Landreneau RJ. The clinical significance of hepatocyte growth factor for non-small cell lung cancer. Ann Thorac Surg 1998;66: 1915-8.
23. Guan JL, Shalloway D. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 1992;358: 690-2.
24. Wary KK, Mainiero F, Isakoff SJ, Marcantonio EE, Giancotti FG. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 1996;87: 733-43.
25. Ji HF, Pang D, Fu SB, Jin Y, Yao L, Qi JP, et al. Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer. J Cancer Res Clin Oncol 2013;139: 429-35.
26. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3: 453-8.
27. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127: 679-95.
28. Brabletz S, Brabletz T. The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep 2010; 11: 670-7.
29. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009;11: 1487-95.
30. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009;138: 592-603.